- Investing Ideas
- /
- U.S. Established, Profitable and Undervalued
U.S. Established, Profitable and Undervalued
Results
490
0 new
Over $1bn in market cap, profitable and undervalued based on cash flows.
490 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
AAPL | US$226.80 | -0.4% | 27.8% | US$3.4t | US$240.01 | PE33.8x | E7.8% | 0.4% | Tech | ||
MSFT | US$416.06 | -2.8% | 27.1% | US$3.1t | US$501.75 | PE35.1x | E12.4% | 0.8% | Software | ||
GOOGL | US$167.06 | 1.9% | 21.4% | US$2.1t | US$202.48 | PE23.5x | E12.4% | 0.5% | Media | ||
AMZN | US$186.51 | -0.8% | 45.8% | US$2.0t | US$220.76 | PE44.1x | E19.9% | n/a | Retail | ||
META | US$595.94 | 5.0% | 88.9% | US$1.5t | US$590.40 | PE29.3x | E11.6% | 0.3% | Media | ||
LLY | US$887.16 | 1.1% | 57.0% | US$798.8b | US$995.42 | PE108.8x | E28.5% | 0.6% | Pharmaceuticals & Biotech | ||
WMT | US$80.94 | 1.5% | 55.2% | US$650.6b | US$82.64 | PE41.8x | E12.4% | 1.0% | Consumer Retailing | ||
JPM | US$211.22 | 0.3% | 45.6% | US$601.0b | US$221.42 | PB1.9x | E-3.7% | 2.2% | Banks | ||
XOM | US$124.83 | 7.8% | 16.5% | US$554.6b | US$130.54 | PE16.2x | E5.1% | 3.0% | Energy | ||
UNH | US$591.20 | 1.6% | 12.7% | US$545.9b | US$623.11 | PE38.7x | E23.4% | 1.4% | Healthcare | ||
V | US$277.93 | 1.0% | 18.2% | US$528.7b | US$306.95 | PE28.1x | E9.6% | 0.7% | Diversified Financials | ||
ORCL | US$170.86 | 1.3% | 55.4% | US$473.5b | US$175.83 | PE43.1x | E16.2% | 0.9% | Software | ||
HD | US$408.36 | 2.2% | 39.5% | US$405.6b | US$389.51 | PE27.5x | E6.0% | 2.2% | Retail | ||
PG | US$168.88 | -2.7% | 17.2% | US$396.8b | US$177.70 | PE27.2x | E6.7% | 2.4% | Household | ||
COST | US$883.11 | -0.3% | 58.4% | US$391.3b | US$924.92 | PE53.1x | E7.5% | 0.5% | Consumer Retailing | ||
JNJ | US$160.29 | -0.7% | 1.7% | US$385.9b | US$171.55 | PE23.6x | E7.2% | 3.1% | Pharmaceuticals & Biotech | ||
ABBV | US$194.29 | -0.3% | 31.1% | US$343.2b | US$197.47 | PE64.8x | E25.3% | 3.2% | Pharmaceuticals & Biotech | ||
BAC | US$40.11 | 1.8% | 53.9% | US$311.2b | US$45.22 | PB1.2x | E7.9% | 2.6% | Banks | ||
NFLX | US$719.70 | 1.7% | 88.6% | US$308.9b | US$699.60 | PE43.5x | E16.1% | n/a | Media | ||
KO | US$70.17 | -2.3% | 32.0% | US$302.4b | US$73.26 | PE28.4x | E8.2% | 2.8% | Food, Beverage & Tobacco | ||
MRK | US$109.77 | -3.4% | 5.7% | US$278.2b | US$138.95 | PE20.3x | E14.4% | 2.8% | Pharmaceuticals & Biotech | ||
AMD | US$170.90 | 4.0% | 59.4% | US$276.6b | US$186.91 | PE204.3x | E39.9% | n/a | Semiconductors | ||
CVX | US$150.74 | 3.6% | -7.1% | US$275.7b | US$170.23 | PE14.7x | E5.4% | 4.3% | Energy | ||
CRM | US$287.75 | 4.0% | 38.8% | US$275.1b | US$313.12 | PE48.8x | E13.9% | 0.6% | Software |